CYTOSORBENTS CORPORATION Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
CYTOSORBENTS CORPORATION (CTSO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.40% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-31
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.40%, a 1350.00% decline from fiscal 2022.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 0.03%.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was 0.00%.
- CYTOSORBENTS CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2023-12-31 | -0.40% 10-K · filed 2025-03-31 | 0.10% 10-K · filed 2024-03-15 |
| 2022-12-31 | 0.03% 10-K · filed 2023-03-09 | |
| 2018-12-31 | 0.00% 10-K · filed 2019-03-07 | |
| 2017-12-31 | 0.00% 10-K · filed 2019-03-07 | |
| 2016-12-31 | 0.00% 10-K · filed 2019-03-07 | |
| 2015-12-31 | 0.00% 10-K · filed 2018-03-08 | |
| 2014-12-31 | 1.00% 10-K · filed 2017-03-03 | -1.00% 10-K · filed 2015-03-31 |
| 2013-12-31 | 0.90% 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |